El Segundo, CANCT06234098Now EnrollingIRB Ready

Advanced Cancer Clinical Trial in El Segundo, CA

Access cutting-edge advanced cancer treatment through this clinical trial at a research site in El Segundo. Study-provided care at no cost to qualified participants.

Sponsored by Alyssum Therapeutics

Quick Self-Assessment

See if you qualify for this El Segundo location

Preparing your pre-screening questions...

Expert Care in El Segundo

Access advanced cancer specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related advanced cancer treatment provided free

Apply for This El Segundo Location

Check if you qualify for this advanced cancer clinical trial in El Segundo, CA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to El Segundo

    Convenient for CA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit El Segundo site if eligible
  4. 4Begin participation

About This Advanced Cancer Study in El Segundo

This is a first-in-human, multicenter, open-label, dose escalation and dose expansion Phase 1/2 study to determine the MTD and/or the recommended Phase 2 dose (RP2D) and to characterize DLTs of AT-1965 as well as to investigate the safety, pharmacokinetics (PK), pharmacodynamics, and preliminary antitumor activity of AT-1965 in patients with advanced, refractory or recurrent solid tumors (nonresectable and/or metastatic) including mTNBC.

Sponsor: Alyssum Therapeutics

Who Can Participate

Inclusion Criteria

The patient has a histologically or cytologically confirmed unresectable or metastatic solid tumor that is refractory to standard therapy or for which in the opinion of the investigator no standard therapy is suitable. 2. Patient should have at least 1 measurable lesion per RECIST version 1.1 as assessed by the investigator. For Part A only, patients with radiographically evaluable but non-measurable disease are allowed after discussion with the sponsor. 3. Recovered from AEs (except irAEs) of prior chemotherapy (per NCI CTCAE version 5.0) to Grade ≤ 1 or return to baseline status (except for alopecia) as per Investigator's discretion. 4. The patient has an ECOG performance status of 0 to 2. 5. The patient has adequate bone marrow, renal, and hepatic function, defined as follows: 1. Hemoglobin ≥9.5 g/dL (without transfusion in the prior 3 weeks). 2. Platelets ≥100 × 109 cells/L (may be achieved with transfusion as per PI discretion) 3. ANC ≥1.5 ×109 ce

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in El Segundo?

Yes, this clinical trial (NCT06234098) has an active research site in El Segundo, CA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Advanced Cancer Treatment Options in El Segundo, CA

If you're searching for advanced cancer treatment options in El Segundo, CA, this clinical trial (NCT06234098) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our El Segundo research site is actively enrolling participants for this clinical trial. You'll receive care from experienced advanced cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all advanced cancer clinical trials near you to find additional studies recruiting in your area.

More Advanced Solid Tumors Trials in El Segundo, CA

See all advanced solid tumors clinical trials recruiting in El Segundo — not just this study.

Browse Advanced Solid Tumors Trials in El Segundo →

Browse More Trials by Condition

Advanced Solid Tumors TrialsAlzheimers Disease TrialsAtopic Dermatitis TrialsErectile Dysfunction TrialsAll Conditions →

Ready to Join in El Segundo?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · El Segundo, CA